Pharm Exec VIDEO Podcast: Emerging Potential: Changing Lives One Story, One Therapeutic at a Time
The 2023 Emerging Pharma Leaders share with the Pharmaceutical Executive editors what makes a good leader, what has made them the proudest in their career, lessons they wish they had known when starting out, and more. (This is the video podcast of the Pharm Exec Podcast episode!)
Each year, Pharmaceutical Executive recognizes up-and-coming leaders who are vital to the future of the pharmaceutical and biotech industry in the Emerging Pharma Leaders (EPL) Awards. Nominations are judged by three members of the Editorial Advisory Board as well as a former EPL representative. This year, five winners were selected, all of whom had incredible journeys to share with the editorial team.
The Pharm Exec team would like to congratulate the 2023 Emerging Pharma Leaders:
- Natasha A. Hernday, chief business officer, Seagen
- Simon Holland, vice president, women's health commercial lead, Organon
- Justin To, chief operating officer, skeletal dysplasias and gene therapy, Bridge Bio
- Frank Watanabe, president and CEO, Arcutis Biotherapeutics
- Hanadie Yousef, PhD, co-founder and CEO, Juvena Therapeutics
In this episode of the Pharm Exec Podcast, Meg Rivers, managing editor, and the editorial team speak with the EPL winners, asking each about:
- Their current role and responsibilities
- What makes a good leader
- What has made them the proudest in their career
- Lessons they wish they had known when starting out
- What’s next for them in their career
Listen to the audio version of this podcast
2023 Emerging Pharma Leaders: Changing Lives One Story, One Therapeutic at a Time
Read about the 2023 Emerging Pharma Leaders:
- Natasha A. Hernday, chief business officer, Seagen
- Simon Holland, vice president, women's health commercial lead, Organon
- Justin To, chief operating officer, skeletal dysplasias and gene therapy, Bridge Bio
- Frank Watanabe, president and CEO, Arcutis Biotherapeutics
- Hanadie Yousef, PhD, co-founder and CEO, Juvena Therapeutics
About the Pharm Exec Podcast
The editors of Pharmaceutical Executive bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
New Insights Into T Cell Exhaustion and Inflammation in Long COVID
April 17th 2025Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and evidence of T cell exhaustion in long COVID patients, providing deeper insight into post-infection immune disruption.
